5HT2c receptor agonists
US7208494B2 · kind B2 · utility
0Cited by
19References
21Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 25, 2004 |
| Grant date | Apr 24, 2007 |
| Priority date | — |
| Expiry date | Dec 13, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides piperazine derivatives of formula (I)as well as pharmaceutically acceptable salts and esters thereof, wherein R1 to R5 have the significance given in the description. They can be used for the treatment of obesity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.